The technology was installed at Aravind Eye Hospital in Madurai, India. The program’s algorithms have proven to be on par with eye physicians and retinal specialists when diagnosing the two eye conditions.
European regulators have since approved the technology’s use in real world scenarios to screen for the conditions, which both can cause blindness.
India is the prominent target for the technology because of the lack of eye physicians and epidemic of diabetic retinopathy in the country. With success at Aravind Eye Hospital, Google and Verily plan to expand the technology to clinics throughout India.
In the U.S., the algorithms are used to assist physicians when sorting through various images to prioritize which patients are most at risk for developing the eye conditions.
More articles on health IT:
Letters to Apple CEO influence developments of health products
Microsoft, Philips to launch augmented reality for minimally invasive surgery: 5 notes
HHS sets release date for interoperability rule: 3 things to know
